Moleculin Biotech, Inc.

MBRX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015
Assets
Cash & Equivalents $7.7M $5.0M $28.0K
Accounts Receivable — — —
Inventory — — —
Total Current Assets $8.3M $5.2M $28.1K
Property, Plant & Equipment $33.0K $23.0K $0
Goodwill — — —
Intangible Assets (Excl. Goodwill) — — —
Total Assets $19.5M $16.4M $28.1K
Liabilities
Accounts Payable $810.0K $399.0K —
Total Current Liabilities $2.2M $1.3M $772.8K
Long-Term Debt — — —
Total Liabilities $2.4M $1.4M $772.8K
Stockholders' Equity
Retained Earnings $-14.5M $-4.7M $-748.4K
Total Stockholders' Equity $17.1M $15.0M $-745.0K
← Newer Page 2 of 2 Older →